Neutralization of mitogenic lectins by intravenous immunoglobulin (IVIg) prevents T cell activation: does IVIg really have a direct effect on T cells?

Intravenous immunoglobulin (IVIg) is used for the treatment of an increasing number of autoimmune diseases. Clinical observations on IVIg-treated patients have revealed a modulation of T cell populations and functions in these patients. In vitro studies aimed at understanding the mechanisms underlyi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Padet, L, St-Amour, I, Aubin, É, Bazin, R
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2011
Gaiak:
Translational Studies
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3232383/
https://ncbi.nlm.nih.gov/pubmed/22059993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2011.04476.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak